Last reviewed · How we verify
ABI-H3733 Solid Oral Dosage Form — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
ABI-H3733 Solid Oral Dosage Form (ABI-H3733 Solid Oral Dosage Form) — Assembly Biosciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ABI-H3733 Solid Oral Dosage Form TARGET | ABI-H3733 Solid Oral Dosage Form | Assembly Biosciences | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ABI-H3733 Solid Oral Dosage Form CI watch — RSS
- ABI-H3733 Solid Oral Dosage Form CI watch — Atom
- ABI-H3733 Solid Oral Dosage Form CI watch — JSON
- ABI-H3733 Solid Oral Dosage Form alone — RSS
Cite this brief
Drug Landscape (2026). ABI-H3733 Solid Oral Dosage Form — Competitive Intelligence Brief. https://druglandscape.com/ci/abi-h3733-solid-oral-dosage-form. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab